KBIO COMPANY Statistics

Total Valuation

KBIO COMPANY has a market cap or net worth of KRW 28.99 billion. The enterprise value is 25.67 billion.

Market Cap	28.99B
Enterprise Value	25.67B

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

KBIO COMPANY has 115.50 million shares outstanding. The number of shares has increased by 3.14% in one year.

Current Share Class	115.50M
Shares Outstanding	115.50M
Shares Change (YoY)	+3.14%
Shares Change (QoQ)	+48.29%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	77.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.35
PB Ratio	0.28
P/TBV Ratio	0.55
P/FCF Ratio	4.95
P/OCF Ratio	4.91
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.87, with an EV/FCF ratio of 4.38.

EV / Earnings	-2.06
EV / Sales	0.31
EV / EBITDA	52.87
EV / EBIT	n/a
EV / FCF	4.38

Financial Position

The company has a current ratio of 9.17, with a Debt / Equity ratio of 0.01.

Current Ratio	9.17
Quick Ratio	7.78
Debt / Equity	0.01
Debt / EBITDA	1.60
Debt / FCF	0.13
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -16.53% and return on invested capital (ROIC) is -0.27%.

Return on Equity (ROE)	-16.53%
Return on Assets (ROA)	-0.25%
Return on Invested Capital (ROIC)	-0.27%
Return on Capital Employed (ROCE)	-0.47%
Revenue Per Employee	2.15B
Profits Per Employee	-319.86M
Employee Count	39
Asset Turnover	0.69
Inventory Turnover	13.80

Taxes

In the past 12 months, KBIO COMPANY has paid 320.22 million in taxes.

Income Tax	320.22M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.23% in the last 52 weeks. The beta is 0.93, so KBIO COMPANY's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	+8.23%
50-Day Moving Average	249.94
200-Day Moving Average	260.36
Relative Strength Index (RSI)	47.88
Average Volume (20 Days)	2,174,634

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KBIO COMPANY had revenue of KRW 83.85 billion and -12.47 billion in losses. Loss per share was -105.61.

Revenue	83.85B
Gross Profit	12.81B
Operating Income	-494.22M
Pretax Income	-18.40B
Net Income	-12.47B
EBITDA	485.51M
EBIT	-494.22M
Loss Per Share	-105.61

Full Income Statement

Balance Sheet

The company has 53.88 billion in cash and 775.19 million in debt, giving a net cash position of 53.11 billion or 459.80 per share.

Cash & Cash Equivalents	53.88B
Total Debt	775.19M
Net Cash	53.11B
Net Cash Per Share	459.80
Equity (Book Value)	103.82B
Book Value Per Share	378.25
Working Capital	61.87B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.90 billion and capital expenditures -39.88 million, giving a free cash flow of 5.86 billion.

Operating Cash Flow	5.90B
Capital Expenditures	-39.88M
Free Cash Flow	5.86B
FCF Per Share	50.74

Full Cash Flow Statement

Margins

Gross margin is 15.28%, with operating and profit margins of -0.59% and -14.88%.

Gross Margin	15.28%
Operating Margin	-0.59%
Pretax Margin	-21.95%
Profit Margin	-14.88%
EBITDA Margin	0.58%
EBIT Margin	-0.59%
FCF Margin	6.99%

Dividends & Yields

KBIO COMPANY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.14%
Shareholder Yield	-3.14%
Earnings Yield	-43.03%
FCF Yield	20.22%

Stock Splits

The last stock split was on April 27, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 27, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

KBIO COMPANY has an Altman Z-Score of 2.96 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.96
Piotroski F-Score	4